Schedule 13G ownership disclosure

Alliqua BioMedical, Inc.

Security class unavailable

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,121,951
Percent of class
6.9400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-15-000226
Form type
SC 13G
Filer
Adynxx, Inc.
CIK
CIK 1054274
Filed
Feb 17, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub